Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia
Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mit...
Gespeichert in:
Veröffentlicht in: | Human gene therapy 2022-08, Vol.33 (15-16), p.801-809 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 809 |
---|---|
container_issue | 15-16 |
container_start_page | 801 |
container_title | Human gene therapy |
container_volume | 33 |
creator | Naiki, Yasuhiro Miyado, Mami Shindo, Miyuki Horikawa, Reiko Hasegawa, Yuichi Katsumata, Noriyuki Takada, Shuji Akutsu, Hidenori Onodera, Masafumi Fukami, Maki |
description | Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11β-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) (n = 4), 17α-hydroxylase/17,20 lyase deficiency (CYP17A1D) (n = 1), and 11β-hydroxylase deficiency (CYP11B1D) (n = 1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11β-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1-containing AAV9 vectors into the adrenal gland of Cyp11b1-deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction. |
doi_str_mv | 10.1089/hum.2022.005 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2691057957</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2691057957</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-9f538af4ce35032d4bf2e6a7220581ad47e10a273a29bbb43e27235353a520993</originalsourceid><addsrcrecordid>eNpdkctKxDAUhosoeN35AAEXupiO6UnTTJfD4A0UBS_bctqcaqST1CRdzLP4skbGlRw4F87Hzw9_lp0WfF7wRX35Ma3nwAHmnMud7KCQUuWqBNhNOy9FzkUJ-9lhCJ-cF0JW6iD7XmqyLl-G4DqDkTR7M34K-QPp7XlDltjLB3kcN6x3nj1hNGRjOGfXpvWuHTDEMGN3Vk9d4p-GyZvRxYSw50hrtqJhSH-0miF7cFOg1DUNzPVs5ew7WRNxYEvtyaZ5uxnJj0nU4HG21-MQ6ORvHmWv11cvq9v8_vHmbrW8zztRQczrXooF9mVHQnIBumx7oAoVAJeLAnWpqOAISiDUbduWgkCBkKlQAq9rcZRdbHVH774mCrFZm9Al22gp-W2gqgsuVS1VQs_-oZ9u8sl3ohSHsqqEgETNtlTnXQie-mb0Zo1-0xS8-U2qSUk1v0k1KSnxA0oJhqY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2702466332</pqid></control><display><type>article</type><title>Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia</title><source>Alma/SFX Local Collection</source><creator>Naiki, Yasuhiro ; Miyado, Mami ; Shindo, Miyuki ; Horikawa, Reiko ; Hasegawa, Yuichi ; Katsumata, Noriyuki ; Takada, Shuji ; Akutsu, Hidenori ; Onodera, Masafumi ; Fukami, Maki</creator><creatorcontrib>Naiki, Yasuhiro ; Miyado, Mami ; Shindo, Miyuki ; Horikawa, Reiko ; Hasegawa, Yuichi ; Katsumata, Noriyuki ; Takada, Shuji ; Akutsu, Hidenori ; Onodera, Masafumi ; Fukami, Maki</creatorcontrib><description>Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11β-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) (n = 4), 17α-hydroxylase/17,20 lyase deficiency (CYP17A1D) (n = 1), and 11β-hydroxylase deficiency (CYP11B1D) (n = 1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11β-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1-containing AAV9 vectors into the adrenal gland of Cyp11b1-deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction.</description><identifier>ISSN: 1043-0342</identifier><identifier>EISSN: 1557-7422</identifier><identifier>DOI: 10.1089/hum.2022.005</identifier><language>eng</language><publisher>New Rochelle: Mary Ann Liebert, Inc</publisher><subject>Adrenal glands ; Cell differentiation ; Corticosterone ; CRISPR ; Cytochrome ; Cytochrome P450 ; Cytochromes P450 ; Defects ; Enzymatic activity ; Enzymes ; Fibroblasts ; Gene therapy ; Hereditary diseases ; Hydroxylase ; Hyperplasia ; Injection ; Metabolism ; Mitochondria ; Pluripotency ; Stem cell transplantation ; Stem cells ; Steroid 11β-hydroxylase ; Viruses</subject><ispartof>Human gene therapy, 2022-08, Vol.33 (15-16), p.801-809</ispartof><rights>Copyright Mary Ann Liebert, Inc. Aug 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-9f538af4ce35032d4bf2e6a7220581ad47e10a273a29bbb43e27235353a520993</citedby><cites>FETCH-LOGICAL-c362t-9f538af4ce35032d4bf2e6a7220581ad47e10a273a29bbb43e27235353a520993</cites><orcidid>0000-0002-6338-895X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Naiki, Yasuhiro</creatorcontrib><creatorcontrib>Miyado, Mami</creatorcontrib><creatorcontrib>Shindo, Miyuki</creatorcontrib><creatorcontrib>Horikawa, Reiko</creatorcontrib><creatorcontrib>Hasegawa, Yuichi</creatorcontrib><creatorcontrib>Katsumata, Noriyuki</creatorcontrib><creatorcontrib>Takada, Shuji</creatorcontrib><creatorcontrib>Akutsu, Hidenori</creatorcontrib><creatorcontrib>Onodera, Masafumi</creatorcontrib><creatorcontrib>Fukami, Maki</creatorcontrib><title>Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia</title><title>Human gene therapy</title><description>Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11β-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) (n = 4), 17α-hydroxylase/17,20 lyase deficiency (CYP17A1D) (n = 1), and 11β-hydroxylase deficiency (CYP11B1D) (n = 1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11β-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1-containing AAV9 vectors into the adrenal gland of Cyp11b1-deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction.</description><subject>Adrenal glands</subject><subject>Cell differentiation</subject><subject>Corticosterone</subject><subject>CRISPR</subject><subject>Cytochrome</subject><subject>Cytochrome P450</subject><subject>Cytochromes P450</subject><subject>Defects</subject><subject>Enzymatic activity</subject><subject>Enzymes</subject><subject>Fibroblasts</subject><subject>Gene therapy</subject><subject>Hereditary diseases</subject><subject>Hydroxylase</subject><subject>Hyperplasia</subject><subject>Injection</subject><subject>Metabolism</subject><subject>Mitochondria</subject><subject>Pluripotency</subject><subject>Stem cell transplantation</subject><subject>Stem cells</subject><subject>Steroid 11β-hydroxylase</subject><subject>Viruses</subject><issn>1043-0342</issn><issn>1557-7422</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpdkctKxDAUhosoeN35AAEXupiO6UnTTJfD4A0UBS_bctqcaqST1CRdzLP4skbGlRw4F87Hzw9_lp0WfF7wRX35Ma3nwAHmnMud7KCQUuWqBNhNOy9FzkUJ-9lhCJ-cF0JW6iD7XmqyLl-G4DqDkTR7M34K-QPp7XlDltjLB3kcN6x3nj1hNGRjOGfXpvWuHTDEMGN3Vk9d4p-GyZvRxYSw50hrtqJhSH-0miF7cFOg1DUNzPVs5ew7WRNxYEvtyaZ5uxnJj0nU4HG21-MQ6ORvHmWv11cvq9v8_vHmbrW8zztRQczrXooF9mVHQnIBumx7oAoVAJeLAnWpqOAISiDUbduWgkCBkKlQAq9rcZRdbHVH774mCrFZm9Al22gp-W2gqgsuVS1VQs_-oZ9u8sl3ohSHsqqEgETNtlTnXQie-mb0Zo1-0xS8-U2qSUk1v0k1KSnxA0oJhqY</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Naiki, Yasuhiro</creator><creator>Miyado, Mami</creator><creator>Shindo, Miyuki</creator><creator>Horikawa, Reiko</creator><creator>Hasegawa, Yuichi</creator><creator>Katsumata, Noriyuki</creator><creator>Takada, Shuji</creator><creator>Akutsu, Hidenori</creator><creator>Onodera, Masafumi</creator><creator>Fukami, Maki</creator><general>Mary Ann Liebert, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6338-895X</orcidid></search><sort><creationdate>20220801</creationdate><title>Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia</title><author>Naiki, Yasuhiro ; Miyado, Mami ; Shindo, Miyuki ; Horikawa, Reiko ; Hasegawa, Yuichi ; Katsumata, Noriyuki ; Takada, Shuji ; Akutsu, Hidenori ; Onodera, Masafumi ; Fukami, Maki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-9f538af4ce35032d4bf2e6a7220581ad47e10a273a29bbb43e27235353a520993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adrenal glands</topic><topic>Cell differentiation</topic><topic>Corticosterone</topic><topic>CRISPR</topic><topic>Cytochrome</topic><topic>Cytochrome P450</topic><topic>Cytochromes P450</topic><topic>Defects</topic><topic>Enzymatic activity</topic><topic>Enzymes</topic><topic>Fibroblasts</topic><topic>Gene therapy</topic><topic>Hereditary diseases</topic><topic>Hydroxylase</topic><topic>Hyperplasia</topic><topic>Injection</topic><topic>Metabolism</topic><topic>Mitochondria</topic><topic>Pluripotency</topic><topic>Stem cell transplantation</topic><topic>Stem cells</topic><topic>Steroid 11β-hydroxylase</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Naiki, Yasuhiro</creatorcontrib><creatorcontrib>Miyado, Mami</creatorcontrib><creatorcontrib>Shindo, Miyuki</creatorcontrib><creatorcontrib>Horikawa, Reiko</creatorcontrib><creatorcontrib>Hasegawa, Yuichi</creatorcontrib><creatorcontrib>Katsumata, Noriyuki</creatorcontrib><creatorcontrib>Takada, Shuji</creatorcontrib><creatorcontrib>Akutsu, Hidenori</creatorcontrib><creatorcontrib>Onodera, Masafumi</creatorcontrib><creatorcontrib>Fukami, Maki</creatorcontrib><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Human gene therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Naiki, Yasuhiro</au><au>Miyado, Mami</au><au>Shindo, Miyuki</au><au>Horikawa, Reiko</au><au>Hasegawa, Yuichi</au><au>Katsumata, Noriyuki</au><au>Takada, Shuji</au><au>Akutsu, Hidenori</au><au>Onodera, Masafumi</au><au>Fukami, Maki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia</atitle><jtitle>Human gene therapy</jtitle><date>2022-08-01</date><risdate>2022</risdate><volume>33</volume><issue>15-16</issue><spage>801</spage><epage>809</epage><pages>801-809</pages><issn>1043-0342</issn><eissn>1557-7422</eissn><abstract>Congenital adrenal hyperplasia (CAH) is an autosomal recessive disorder caused by steroidogenic enzymes containing monogenetic defects. Most steroidogenic enzymes are cytochrome P450 groups that can be categorized as microsomal P450s, including 21-hydroxylase and 17α-hydroxylase/17,20 lyase, and mitochondrial P450s, including 11β-hydroxylase. It has been shown that ectopic administration of Cyp21a1 ameliorates steroid metabolism in 21-hydroxylase-deficient mice. However, the effectiveness of this approach for mitochondrial P450 has not yet been evaluated. In this study, primary fibroblasts from patients with 21-hydroxylase deficiency (CYP21A2D) (n = 4), 17α-hydroxylase/17,20 lyase deficiency (CYP17A1D) (n = 1), and 11β-hydroxylase deficiency (CYP11B1D) (n = 1) were infected with adeno-associated virus type 2 (AAV2) vectors. Steroidogenic enzymatic activity was not detected in the AAV2-infected CYP11B1D fibroblasts. Induced pluripotent stem cells (iPSCs) of CYP11B1D were established and differentiated into adrenocortical cells by induction of the NR5A1 gene. Adrenocortical cells established from iPSCs of CYP11B1D (CYP11B1D-iPSCs) were infected with an AAV type 9 (AAV9) vector containing CYP11B1 and exhibited 11β-hydroxylase activity. For an in vivo evaluation, we knocked out Cyp11b1 in mice by using the CRISPR/Cas9 method. Direct injection of Cyp11b1-containing AAV9 vectors into the adrenal gland of Cyp11b1-deficient mice significantly reduced serum 11-deoxycorticosterone/corticosterone ratios at 4 weeks after injection and the effect was prolonged for up to 12 months. This study indicated that CYP11B1D could be ameliorated by gene induction in the adrenal glands, which suggests that a defective-enzyme-dependent therapeutic strategy for CAH would be required. Defects in microsomal P450, including CYP21A2D and CYP17A1D, can be treated with extra-adrenal gene induction. However, defects in mitochondrial P450, as represented by CYP11B1D, may require adrenal gene induction.</abstract><cop>New Rochelle</cop><pub>Mary Ann Liebert, Inc</pub><doi>10.1089/hum.2022.005</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0002-6338-895X</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1043-0342 |
ispartof | Human gene therapy, 2022-08, Vol.33 (15-16), p.801-809 |
issn | 1043-0342 1557-7422 |
language | eng |
recordid | cdi_proquest_miscellaneous_2691057957 |
source | Alma/SFX Local Collection |
subjects | Adrenal glands Cell differentiation Corticosterone CRISPR Cytochrome Cytochrome P450 Cytochromes P450 Defects Enzymatic activity Enzymes Fibroblasts Gene therapy Hereditary diseases Hydroxylase Hyperplasia Injection Metabolism Mitochondria Pluripotency Stem cell transplantation Stem cells Steroid 11β-hydroxylase Viruses |
title | Adeno-Associated Virus-Mediated Gene Therapy for Patients' Fibroblasts, Induced Pluripotent Stem Cells, and a Mouse Model of Congenital Adrenal Hyperplasia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T08%3A08%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adeno-Associated%20Virus-Mediated%20Gene%20Therapy%20for%20Patients'%20Fibroblasts,%20Induced%20Pluripotent%20Stem%20Cells,%20and%20a%20Mouse%20Model%20of%20Congenital%20Adrenal%20Hyperplasia&rft.jtitle=Human%20gene%20therapy&rft.au=Naiki,%20Yasuhiro&rft.date=2022-08-01&rft.volume=33&rft.issue=15-16&rft.spage=801&rft.epage=809&rft.pages=801-809&rft.issn=1043-0342&rft.eissn=1557-7422&rft_id=info:doi/10.1089/hum.2022.005&rft_dat=%3Cproquest_cross%3E2691057957%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2702466332&rft_id=info:pmid/&rfr_iscdi=true |